Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
12/2013
12/26/2013US20130345276 Synthetic triterpenoids and methods of use in the treatment of disease
12/26/2013US20130345275 1,3-dihydroimidazole-2-thione derivatives as inhibitors of dopamine-beta-hydroxylase
12/26/2013US20130345274 Allantoin-containing skin cream
12/26/2013US20130345272 Cycloalkyl Ether Compounds and Their Use as Bace Inhibitors
12/26/2013US20130345265 Oral Dosage Form Containing A Pde 4 Inhibitor As An Active Ingredient And Polyvinylpyrrolidon As Excipient
12/26/2013US20130345264 Substituted n-aryl pyridones
12/26/2013US20130345262 Method for prevention of stroke
12/26/2013US20130345259 Use of Levocabastine for Modulating Generation of Pro-Inflammatory Cytokines
12/26/2013US20130345257 Composition for lupus nephritis and methods of making and using the same
12/26/2013US20130345256 N-ethyl-4-hydroxyl-1-methyl-5-(methyl(2,3,4,5,6-pentahydroxyhexyl)amino)-2-oxo-n-phenyl-1,2-dihydroquinoline-3-carboxamide
12/26/2013US20130345255 Trpv1 antagonists
12/26/2013US20130345253 Novel cabergoline derivatives
12/26/2013US20130345250 Anti-nausea drug combinations
12/26/2013US20130345249 Formulations for the prevention and treatment of Wolbachia-related disease
12/26/2013US20130345248 Cyclohexane-1,2'-Naphthalene-1',2"-Imidazol Compounds and Their Use as Bace
12/26/2013US20130345247 Cyclohexane-1,2'-Indene-1',2"-Imidazol Compounds and Their Use as Bace Inhibitors
12/26/2013US20130345246 2H-Imidazol-4-Amine Compounds and Their Use as Bace Inhibitors
12/26/2013US20130345245 Substituted pyrimidinylpyrrolopyridinone derivatives, process for their preparation and their use as kinase inhibitors
12/26/2013US20130345244 Local treatment of neurofibromas
12/26/2013US20130345239 Novel crystalline form
12/26/2013US20130345238 Method of using diketopiperazines and composition containing them
12/26/2013US20130345236 Pharmaceutical compositions providing enhanced drug concentrations
12/26/2013US20130345232 Methods and compositions for treating a subject for a lymphatic malformation
12/26/2013US20130345231 Anticancer therapeutic agents
12/26/2013US20130345230 Methods and compositions for modulating calcium channels
12/26/2013US20130345229 Compositions and Methods for the Treatment of Nasal Conditions
12/26/2013US20130345227 Pyrido [2, 3 - b] pyrazine derivatives and their therapeutical uses
12/26/2013US20130345225 Diazabenzo[de] anthracen-3-one compounds and methods for inhibiting parp
12/26/2013US20130345220 Compounds and compositions as lxr modulators
12/26/2013US20130345217 Combinations of phosphoinositide 3-kinase inhibitor compounds and chemotherapeutic agents, and methods of use
12/26/2013US20130345216 Certain chemical entities, compositions and methods
12/26/2013US20130345214 Lipoxygenase Inhibitors
12/26/2013US20130345209 Aminotriazolopyridine for use in the treatment of inflammation, and pharmaceutical compositions thereof
12/26/2013US20130345207 Benzyl-oxathiazine derivatives substituted with adamantane and noradamantane, medicaments containing said compounds and use thereof
12/26/2013US20130345202 Flumazenil Complexes, Compositions Comprising Same And Uses Thereof
12/26/2013US20130345201 Pharmaceutical combination
12/26/2013US20130345197 Azaindoles useful as inhibitors of jak and other protein kinases
12/26/2013US20130345196 Phenoxy thiophene sulfonamides and other compounds for use as inhibitors of bacterial glucuronidase
12/26/2013US20130345194 Substituted cyclopentyl-azines as casr-active compounds
12/26/2013US20130345190 Isoxazole beta-lactamase inhibitors
12/26/2013US20130345187 Method for pre-screening and correlation of underlying scarb1 gene variation to infertility in women and therapeutic use of progestational and other medications in treatment
12/26/2013US20130345185 Ophthalmic Compositions
12/26/2013US20130345184 Pharmaceutical solid state forms-2
12/26/2013US20130345183 Intravenous formulation with water-soluble cocrystals of acetylsalicylic acid and theanine
12/26/2013US20130345182 Stable composition comprising cholesterol-lowering agents, antihypertensive agents and antiplatlet agents
12/26/2013US20130345180 2,4- diaminopyrimidine derivatives
12/26/2013US20130345177 Oleyl Phosphocholine for the Treatment of Mycosis
12/26/2013US20130345176 NOVEL ESTERS OF 4, 9-DIHYDROXY-NAPHTHO [2, 3-b] FURANS FOR DISEASE THERAPIES
12/26/2013US20130345172 Cyclic boronic acid ester derivatives and therapeutic uses thereof
12/26/2013US20130345171 Treatment and prevention of cardiovascular disease and thrombosis
12/26/2013US20130345169 Article Suitable for Oral Administration
12/26/2013US20130345167 Hypersulfated disaccharide formulations
12/26/2013US20130345166 Methods of treating hepatic encephalopathy
12/26/2013US20130345165 Combination therapeutic composition
12/26/2013US20130345164 Treatments for cellular proliferative disorders and identification thereof
12/26/2013US20130345163 Biological marker for inflammation
12/26/2013US20130345160 Glycyrrhizin high-concentration preparation
12/26/2013US20130345158 COMPOSITION FOR PROMOTING HEMATOGENESIS CONTAINING QUERCETIN 3-O-beta-(2''-GALLOYL)-RHAMNOPYRANOSIDE AS ACTIVE INGREDIENT
12/26/2013US20130345156 Aqueous solution of 20(r)-ginsenoside rg3 pharmaceutical composition and process thereof
12/26/2013US20130345154 Gap Junction-Enhancing Agents for Treatment of Necrotizing Enterocolitis and Inflammatory Bowel Disease
12/26/2013US20130345149 Silicone-based ophthalmic formulations
12/26/2013US20130345148 Prevention and treatment of ocular side effects with a cyclosporin
12/26/2013US20130345146 Near-infrared electromagnetic modification of cellular steady-state membrane potentials
12/26/2013US20130345145 Atip3 and biologically active fragments thereof for use in the treatment of cancer
12/26/2013US20130345140 Basement Membrane Compositions and Applications Thereof
12/26/2013US20130345139 Composition for nutrition purposes
12/26/2013US20130345130 Pharmaceutical composition for preventing or treating heart failure and method for screening agent for preventing or treating heart failure
12/26/2013US20130345128 Oxathiazine derivatives substituted with carbocycles or heterocycles, method for producing same, drugs containing said compounds, and use thereof
12/26/2013US20130345127 Novel substituted phenyl-oxathiazine derivatives, method for producing them, drugs containing said compounds and the use thereof
12/26/2013US20130345126 Branched oxathiazine derivatives, method for the production thereof, use thereof as medicine and drug containing said derivatives and use thereof
12/26/2013US20130345125 Di- and tri-substituted oxathiazine derivatives, method for the production thereof, use thereof as medicine and drug containing said derivatives and use thereof
12/26/2013US20130345123 Substituted adipic acid amides and uses thereof
12/26/2013US20130344184 Materials and methods for treatment and diagnosis of disorders associated with oxidative stress
12/26/2013US20130344182 Novel use of panduratin derivatives or an extract of boesenbergia pandurata for promoting muscle mass growth, fighting fatigue, and enhancing exercise performance capability
12/26/2013US20130344180 Weight loss and satiation composition
12/26/2013US20130344174 Bioactive Fractions and Compounds from Polygonum genus, their Use in Anti-diarrhea and the Method of Preparation
12/26/2013US20130344171 Acidic dialysis concentrate
12/26/2013US20130344167 Galenic Composition Suitable for Administration to a Non-Human Animal, Uses Thereof, and Associated Methods
12/26/2013US20130344166 Topical mixture and method for dermal application to remove excess iron and other heavy metals from cellular tissue
12/26/2013US20130344158 Therapeutic Polymeric Nanoparticles with mTOR Inhibitors and Methods of Making and Using Same
12/26/2013US20130344156 Pharmaceutical compositions of hydrophobic surface-modified active substance microparticles for inhalation
12/26/2013US20130344155 Fenofibrate formulation
12/26/2013US20130344151 Solid pharmaceutical composition comprising telithromycin
12/26/2013US20130344150 Direct compression tablets of otilonium
12/26/2013US20130344149 Oral Dosage Forms for Modified Release Comprising Tasocitinib
12/26/2013US20130344146 Dry formulations of aripiprazole
12/26/2013US20130344145 Orally administered pharmaceutical composition for the treatment of irritable bowel syndrome, comprising an intestinal motility modifier, an agent that prevents gas retention, and digestive enzymes, and preparation method thereof
12/26/2013US20130344143 Formulations of nonopioid and confined opioid analgesics
12/26/2013US20130344141 Concentration and mental performance amplifying formulation
12/26/2013US20130344140 Novel pharmaceutical combinations and methods for treating cancer
12/26/2013US20130344139 Method of reducing contact lens intolerance with non-drying antihistamines
12/26/2013US20130344138 Methods of treatment for solid tumors
12/26/2013US20130344136 Composition comprising diamine oxidase for the prevention of hangover symptoms
12/26/2013US20130344134 Inhibitors of cyclic amp phosphodiesterases
12/26/2013US20130344133 In Vivo Delivery of Nucleic Acids to the Liver or Liver Tissue
12/26/2013US20130344132 Sustained-release liposomal anesthetic compositions
12/26/2013US20130344128 Method for treating ocular demodex
12/26/2013US20130344125 Drug delivery device
12/26/2013US20130344117 Pegylated polyplexes for polynucleotide delivery
12/26/2013US20130344079 Compositions and methods for diagnosing and treating phenylketonuria (pku)
1 ... 438 439 440 441 442 443 444 445 446 447 448 449 450 451 452 453 454 455 456 457 458 ... 7860